Overall, this study uncovers the singularity of TERT compared to other conserved tumor antigens and the potential importance of a TERT-based B-T cooperation in the generation of an active antitumor immunity providing clinical benefit in HNSCC. The gene discussed is TERT; the disease is neoplasm.